Recent Posts

1. 

   2200 cuts coming. How many from sales?

   first we need to cut the PPK cubicle cucks

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 11:12 AM

2. 

   Y'all getting NN from MDT?

   NN can't shut down division X, cause ZB is too small to write off that much $$. They also paid too much for it only a few years ago, and there are no interested buyers at a similar valuation. So bruh, he stuck. Can't do the shut and run.

   Zimmer

   anonymous

   Apr 25, 2024 at 11:11 AM

3. 

   The stock price

   Let’s go back and revisit a comparison with a large pharma peer. Like PFE, they also operate in oncology, vaccines and other small molecule products. On a day that the overall market is tanking and PFE is currently down 2.5% on the day, MRK is...

   Pfizer

   anonymous

   Apr 25, 2024 at 11:03 AM

4. 

   Restructure

   What do expect from a kid?

   Otsuka

   anonymous

   Apr 25, 2024 at 11:03 AM

5. 

   Get ready for "Project Shuffle"

   The stupid language they use to describe the new model is hilarious. I think they could save a lot of money by getting rid of the stupid company chat feature. Perhaps the Europeans would work more? Also why are all these important town halls...

   UCB Pharma

   anonymous

   Apr 25, 2024 at 11:01 AM

6. 

   Lay off in CV for jardiance

   Not saying there will be a down sizing soon but if there is, what time period are people thinking?

   Boehringer Ingelheim

   anonymous

   Apr 25, 2024 at 10:57 AM

7. 

   Pulse now annually

   The pulse of Pulse has stopped, no one listens, who cares and if we don’t ask, we don’t get

   AstraZeneca

   anonymous

   Apr 25, 2024 at 10:57 AM

8. + Show More